SCHEMBL14415656

SCHEMBL14415656

COc1ccc(/C(=C\CN)c2cccc(F)c2)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
RAB9A P51151 4/20 0.46
LMNA P02545 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44
NPC1 O15118 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
PTGS1 P23219 1/20 0.40
NFE2L2 Q16236 1/20 0.40
ACHE P22303 1/20 0.39
ADRB2 P07550 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001610 0.83 PARP1 (0.50) PTGS1MEN1KMT2A
SCHEMBL14415635 0.82 NPC1 (0.59) RAB9APDE4APDE4BPDE4CPDE4D
SCHEMBL6001349 0.78 PARP1 (0.46) RAB9ALMNAHTTNPC1PKM
SCHEMBL14415619 0.78 PARP1 (0.46) RAB9ALMNAHTTNPC1PKM
SCHEMBL6001346 0.78 PARP1 (0.46) RAB9ALMNAHTTNPC1PKM
SCHEMBL5520271 0.77 RAB9A (0.61) CYP1A2RAB9ALMNAMAPK1HTT
SCHEMBL5999478 0.72 MTNR1A (0.60) RAB9APDE4APDE4BPDE4CPDE4D
SCHEMBL30622701 0.68 HTT (0.65) CYP1A2RAB9ALMNAMAPK1HTT
SCHEMBL6582492 0.68 HTT (0.65) CYP1A2RAB9ALMNAMAPK1HTT
SCHEMBL8050011 0.68 HTT (0.65) CYP1A2RAB9ALMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed
US-7268166-B2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases NPS PHARMACEUTICALS, INC. (US) 2007-09-11 US disclosed